Supercharged immune cells battle tough leukemia in groundbreaking trial
NCT ID NCT02782546
Summary
This study tests whether giving patients a special type of 'memory-like' immune cell after a half-matched bone marrow transplant can help keep leukemia from coming back. It's for adults with high-risk acute myeloid leukemia that hasn't responded well to standard treatments. Researchers aim to improve survival rates by boosting the body's natural cancer-fighting defenses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.